TSH) 0.11 mU/L (0.35 to 5.5), free triiodothyronine (T3) 5.2 (3.5 to 6.5), free thyroxine (T4) 18 (11 to 23), and thyroglobulin 25.5 (< 43). Other routine blood tests and computed tomography imaging of her head were normal. Given the suppressed TSH, she was diagnosed with borderline hyperthyroidism.
While in hospital, the patient received olanzapine dissolvable 5 to 7.5 mg once daily, and her manic symptoms abated over a week-long hospital stay. After discharge, she did not continue taking medications. On follow-up a month later, the patient had resumed her usual activities and was euthymic. At this time, lab tests were done and showed a normal thyroid profile.
In the case of borderline hyperthyroidism, it may be difficult to establish whether the hyperthyroid state is the etiologic cause, a contributing factor to the manic episode, or simply comorbid with BD. In this case, it is reasonable to postulate that the hyperthyroid state contributed to the manic episode or precipitated a manic episode in a patient predisposed to BD. This is further supported by the fact that the patient's symptoms resolved without further medications and were coincident with normalization of her thyroid profile. This reinforces the concept that perturbations in the thyroid function may be tied to manic symptomatology. At this time, the patient's preliminary diagnosis is secondary mania, and longitudinal follow-up of her mood symptoms and thyroid function may lead to a more definitive diagnosis. If she had another manic episode without clinical or laboratory indicators of hyperthyroidism, primary BD would be the diagnosis. Notwithstanding the diagnostic dilemma, we suggest that monitoring TSH is appropriate for patients with BD. For patients with recurrent or poorly controlled manic symptoms, it may be informative to see whether the manic symptoms coincide with changes in thyroid function. In conclusion, this case underscores the importance of monitoring TSH in patients with manic episodes.
Dyslipidaemia and Psychiatric Patients
Dear Editor: Associations between atypical antipsychotics (ATPs), weight gain (1), and diabetes (2) have been reported, and links between some ATPs and dyslipidaemia, particularly elevated triglycerides, have been identified (3). Dyslipidaemia is a major contributor to cardiovascular disease and 36% of deaths (over 78 900) in Canada yearly are due to diseases of the circulatory system (4). Raised C-reactive protein is also seen as a strong predictor of a cardiovascular event (5) .
Nine months ago, I began routinely testing patients' lipid, C-reactive protein, and blood glucose levels. So far, I have tested 89 patients, about one-sixth of my practice. Among those patients tested, 67% had a two-fold or more risk of a cardiovascular event, based on a raised total cholesterol/HDL-C ratio. This held true whether the patient was on a conventional antipsychotic, (11 of 13 or 85%) , an ATP (25 of 41or 61%, or no antipsychotic (25 of 35 or 66%). Elevated C-reactive protein was present in 8% of patients. The screening process did not allow for any attribution of cause or determination of how long the elevated levels had been present.
Monitoring weight, blood glucose, and lipids should become routine psychiatric practice, and where necessary, the primary physician should be alerted. These measures are not routinely done in psychiatric inpatient settings, and a recent survey found that only about 50% of inpatients were checked for blood glucose and weight (6) . Encouraging healthy diets, weight loss, and exercise is necessary. However, results of exercise programs may not be encouraging, as motivation is crucial (7) . Medical management, including the use of statins, may be indicated.
If my results are characteristic of a general adult psychiatric population, all patients, regardless of diagnosis and treatment, should be appropriately screened and monitored. Psychiatric populations, for various reasons, appear to be at increased risk of cardiovascular disease.
Robin Menzies, MB, BS, MRCPsych, FRCPC Saskatoon, Saskatchewan

Dream Contents in Patients With Major Depressive Disorder
Dear Editor: The ancients attributed great importance to dreams. Special temples built by the ancient Chinese, Egyptians, Greeks, and Romans were sanctuaries to which people retreated to understand the meaning of their dreams. Hippocrates (469-399 BC) and Galen (ca 130 AD) believed dreams could have psychological and diagnostic utility (1) . Dreaming is one of the interesting aspects of human beings, and physicians could find important information about their patients by exploring their dreams. Dreaming also has several psychological functions, one of which is mood regulation, in healthy subjects (2) .
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